title: Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.
abstract: Peramivir is a neuraminidase (NA) inhibitor (NAI) under development that must be administered by the systemic route. The prophylactic activity of intramuscular (IM) peramivir was evaluated with mice infected with wild-type (WT) and oseltamivir-resistant (H274Y NA mutant) recombinant influenza A/WSN/33 (H1N1) viruses. Treatment regimens consisted of IM injections starting 1 h before viral challenge that were single (45 mg/kg or 90 mg/kg) or multiple (45 mg/kg daily for 5 days). All peramivir regimens prevented mortality and weight loss while significantly reducing lung viral titers (LVT) in mice infected with the WT virus. For animals infected with the H274Y mutant, the multiple-dose regimen completely prevented mortality and was associated with significant reduction in weight loss and LVT compared to untreated animals. In contrast, both single-treatment regimens reduced mortality and weight loss but did not significantly reduce LVT. Although further experiments using different influenza A/H1N1 virus strains and other animal models are needed, our results suggest that 5-day IM peramivir therapy may be considered a prophylactic alternative to control influenza infections caused by oseltamivir-resistant viruses with the H274Y mutation.
authors.affiliation: Research Center in Infectious Diseases of the CHUQ-CHUL and Laval University, Québec City, Québec, Canada.
authors.forename: Yacine
authors.initials: Y
authors.lastname: Abed
authors.forename: Philippe
authors.initials: P
authors.lastname: Simon
authors.forename: Guy
authors.initials: G
authors.lastname: Boivin
mesh_terms: D000146:Acids, Carbocyclic; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002460:Cell Line; D003517:Cyclopentanes / Q000008:administration & dosage / Q000627:therapeutic use*; D004285:Dogs; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use*; D053118:Influenza A Virus, H1N1 Subtype / Q000201:enzymology* / Q000235:genetics; D007273:Injections, Intramuscular; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D009439:Neuraminidase / Q000235:genetics*; D009976:Orthomyxoviridae Infections / Q000188:drug therapy* / Q000517:prevention & control*; D014764:Viral Proteins / Q000235:genetics*
chemical_list: D000146:Acids, Carbocyclic; D000998:Antiviral Agents; D003517:Cyclopentanes; D006146:Guanidines; D014764:Viral Proteins; D009439:Neuraminidase; C414210:peramivir
references.citation: J Infect Dis. 2010 Mar;201(5):740-5
references.pmid: 20100088
references.citation: JAMA. 2006 Feb 22;295(8):891-4
references.pmid: 16456087
references.citation: N Engl J Med. 2005 Sep 29;353(13):1363-73
references.pmid: 16192481
references.citation: Antimicrob Agents Chemother. 2001 Dec;45(12):3403-8
references.pmid: 11709315
references.citation: Antivir Ther. 2004 Aug;9(4):577-81
references.pmid: 15456089
references.citation: Antiviral Res. 2009 Jul;83(1):90-3
references.pmid: 19501261
references.citation: JAMA. 2009 Mar 11;301(10):1034-41
references.pmid: 19255110
references.citation: Antivir Ther. 2007;12(4 Pt B):603-16
references.pmid: 17944268
references.citation: Antiviral Res. 2002 Jun;54(3):143-7
references.pmid: 12062387
references.citation: Antimicrob Agents Chemother. 2001 Mar;45(3):749-57
references.pmid: 11181355
references.citation: Antivir Ther. 2005;10(8):901-10
references.pmid: 16430195
references.citation: N Engl J Med. 2005 Dec 22;353(25):2667-72
references.pmid: 16371632
references.citation: N Engl J Med. 2009 Dec 3;361(23):2296-7
references.pmid: 19907034
references.citation: Antiviral Res. 2006 Jan;69(1):39-45
references.pmid: 16325932
references.citation: Antiviral Res. 2006 Jun;70(2):1-16
references.pmid: 16513187
references.citation: J Med Chem. 2000 Sep 21;43(19):3482-6
references.pmid: 11000002
references.citation: Antimicrob Agents Chemother. 2009 Feb;53(2):791-3
references.pmid: 19015327